Drug chirality: Impact on pharmaceutical regulation
β Scribed by Andrew J. Hutt
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 418 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0899-0042
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
Over the past two decades, competition in the pharmaceutical industry has been characterized by three factors: 1. Competitive advantage driven by blockbuster drugs 2. Vertical integration from discovery through sales 3. Peripheral role as suppliers in the health care system In this environment, suc
Genomics is defined as a set of related technologies which are focused on the discovery of genes implicated in human disease. Although many of the estimated 100,000 genes in the human genome have been at least partially identified by nucleotide sequence, elucidation of biological function has been a